The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers (2013)
- Authors:
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1007/978-1-4614-6182-1_5
- Subjects: NEOPLASIAS PROSTÁTICAS; RECEPTORES ANDROGÊNICOS; CROMATINA; POLIMORFISMO
- Language: Inglês
- Imprenta:
- ISBN: 9781461461814
- Source:
- Título: Androgen-responsive genes in prostate cancer: regulation, function and clinical applications
- Volume/Número/Paginação/Ano: 348 p
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
NOUSHMEHR, Houtan et al. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers. Androgen-responsive genes in prostate cancer: regulation, function and clinical applications. Tradução . New York: Springer, 2013. . Disponível em: https://doi.org/10.1007/978-1-4614-6182-1_5. Acesso em: 29 dez. 2025. -
APA
Noushmehr, H., Coetzee, S. G., Rhie, S. K., Yan, C., & Coetzee, G. A. (2013). The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers. In Androgen-responsive genes in prostate cancer: regulation, function and clinical applications. New York: Springer. doi:10.1007/978-1-4614-6182-1_5 -
NLM
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Coetzee GA. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers [Internet]. In: Androgen-responsive genes in prostate cancer: regulation, function and clinical applications. New York: Springer; 2013. [citado 2025 dez. 29 ] Available from: https://doi.org/10.1007/978-1-4614-6182-1_5 -
Vancouver
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Coetzee GA. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers [Internet]. In: Androgen-responsive genes in prostate cancer: regulation, function and clinical applications. New York: Springer; 2013. [citado 2025 dez. 29 ] Available from: https://doi.org/10.1007/978-1-4614-6182-1_5 - Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers
- Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer
- Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes
- Molecular patterns at regulatory elements diferentially methylated in glioma
- Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning
- Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication
- Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma
- DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma
- DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
- SpidermiR: an R/Bioconductor package for integrative analysis with miRNA data
Informações sobre o DOI: 10.1007/978-1-4614-6182-1_5 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
